I agree that this site is using cookies. You can find further informations here.
X
Ohe, Y
211  results:
Search for persons X
?
1

Non-reversed Great Saphenous Vein Grafts for Vascular Recon..:

Arikawa, M ; Akazawa, S ; Kageyama, D...
Journal of Plastic, Reconstructive & Aesthetic Surgery.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Patient-reported outcomes with selpercatinib treatment in p..:

Raez, L.E. ; Kang, H. ; Ohe, Y....
ESMO Open.  9 (2024)  5 - p. 103444 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Association between skin toxicity and efficacy of necitumum..:

Watanabe, S. ; Yoshioka, H. ; Sakai, H....
ESMO Open.  9 (2024)  4 - p. 102975 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Real-world outcomes of treatment strategy between first-lin..:

Uehara, Y. ; Takeyasu, Y. ; Yoshida, T....
ESMO Real World Data and Digital Oncology.  5 (2024)  - p. 100058 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Long-term survival with first-line nivolumab plus ipilimuma..:

Borghaei, H. ; Ciuleanu, T.-E. ; Lee, J.-S....
Annals of Oncology.  34 (2023)  2 - p. 173-185 , 2023
Link: https://doi.org/10.1016/..
 
?
6

19P Mortality among EGFR-mutated advanced NSCLC patients af..:

Girard, N. ; Leighl, N. ; Ohe, Y....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S51-S52 , 2023
Link: https://doi.org/10.1016/..
 
?
7

EP11.03-08 Multicenter Pharmacokinetic Study of Pembrolizum..:

Horinouchi, H. ; Ohe, Y. ; Yamanaka, Y....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S622 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Comparison of clinical outcomes of osimertinib and first-ge..:

Tamura, K. ; Yoshida, T. ; Masuda, K....
ESMO Open.  8 (2023)  4 - p. 101594 , 2023
Link: https://doi.org/10.1016/..
 
?
9

First-line nivolumab + ipilimumab in advanced NSCLC: CheckM..:

O'Byrne, K.J. ; Lee, K.H. ; Kim, S.-W....
ESMO Open.  7 (2022)  1 - p. 100394 , 2022
Link: https://doi.org/10.1016/..
 
?
10

EP07.03-004 Efficacy of Thoracic Radiotherapy for Local Pro..:

Uematsu, M. ; Goto, Y. ; Torasawa, M....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S331 , 2022
Link: https://doi.org/10.1016/..
 
?
11

EP08.02-173 Treatment Patterns and Outcomes Among Patients ..:

Sabari, J. ; Pisano, S. ; Gemmler, K....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S488-S489 , 2022
Link: https://doi.org/10.1016/..
 
?
12

EP08.02-118 TRUST-II: A Global Phase II Study for Taletrect..:

Misako, N. ; Sugawara, S. ; Choi, C.-M....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S458 , 2022
Link: https://doi.org/10.1016/..
 
?
13

EP08.02-016 Frontline and Post-Osimertinib Therapy for EGFR..:

Girard, N. ; Besse, B. ; Bernabé Caro, R....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S404-S405 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Nivolumab with carboplatin, paclitaxel, and bevacizumab for..:

Sugawara, S. ; Lee, J.-S. ; Kang, J.-H....
Annals of Oncology.  32 (2021)  9 - p. 1137-1147 , 2021
Link: https://doi.org/10.1016/..
 
?
15

The Prognostic Factors for Radiation Pneumonitis ≥ Grade 2 ..:

Kashihara, T. ; Nakayama, Y. ; Kubo, Y....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. E512-E513 , 2019
Link: https://doi.org/10.1016/..
 
1-15